Healthy Females 16-35 – CMV Vaccine
Cytomegalovirus (CMV) Vaccine
PMG Research of Wilmington
A research study is evaluating an investigational Cytomegalovirus (CMV) vaccine in generally healthy women of childbearing potential.
This research study may be an option if you:
• Are a female 16 – 35 years of age
• Are of childbearing potential
• Are often in contact with children under the age of 5, at home or occupationally
• Have not previously received a CMV vaccine
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and investigational vaccine at no cost.
Patient Commitment Duration
Approximately 3 years, duration may vary
Financial compensation up to $50 per visit will be provided for time and travel expenses.
Number of visits in study
Approximately 8 clinic visits and monthly phone calls